RIVM research shows no causal link between the vaccine against cervical cancer (HPV) and long-term fatigue symptoms in girls.

From mid-September, young people born between 1 May and 31 December 2004 will receive an invitation for a vaccination against meningococcal disease.

The vaccination rate for vaccines included in the National Immunisation Programme has dropped slightly by about 1 percent.

January 20th, the Olive Foundation and RIVM opened AEX trading day in Amsterdam on the occasion of the 9th European Cervical Cancer Prevention Week.

Every year, RIVM provides an overview of surveillance and developments in the National Immunisation Programme (NIP).

In 2014 the number of girls who were immunised against the human papilloma virus (HPV) rose. This virus can cause cervical cancer later in life.

Annually RIVM provides an overview of key events and developments in the National Immunisation Programme (NIP).

January 19 - 25 European Cervical Cancer Prevention Week.

In the Netherlands, there are 80 municipalities with a low vaccination coverage for one or more vaccinations. This is a decrease compared to last year when there were still 90 municipalities.